BNO 5.26% 20.0¢ bionomics limited

Ann: Commencement of BNC210 Phase 2 Agitation Trial, page-9

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 593 Posts.
    lightbulb Created with Sketch. 24
    What would be the control arm of the study DDD? A positive control (Bellamy's over the past 12 months?) or a negative control (Myer shareholders?) or the bears who have fled the market entirely? Its kinda funny to think how best to undertake that sort of trial. Not that I would recommend it be undertaken.
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.